Table of Contents (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on January 31, 2024 Registration No. 333-276648 (State or other jurisdiction of incorporation or organization) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Primary Standard Industrial Classification Code Number) FORM S-1/A Pre-Effective Amendment No. 1 Delaware 8071 47-3324725 (I.R.S. Employer Identification Number) REGISTRATION STATEMENT UNDER THE SECURIT ...

Stock Issuance and Dilution - Aclarion issued 500,000 shares of ACON stock in exchange for $1,185,226 of principal and accrued interest on unsecured non-convertible notes, increasing the total number of outstanding shares to 1,791,375 [1] - The company may enact similar exchanges in the future to cover financing from those notes [1] - Increasing the total number of shares often results in a stock's price falling due to dilution of current investors' stakes [1] ACON Stock Performance - ACON stock is down 15.5% as of Monday morning, with about 367,000 shares traded compared to the daily average trading volume of 1.2 million shares [2] - The stock was down 14.4% year-to-date as of Friday's close [2] Market Context - The article mentions other stocks such as SoFi Technologies (NASDAQ:SOFI), Panbela Therapeutics (NASDAQ:PBLA), and Revelation Biosciences (NASDAQ:REVB) as part of the broader stock market news [2] - InvestorPlace typically avoids publishing commentary on companies with a market cap of less than $100 million or trading less than 100,000 shares daily due to the risks associated with low-volume stocks [3]

Table of Contents As filed with the Securities and Exchange Commission on January 22, 2024 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aclarion, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8071 47-3324725 (I.R.S. Employer Identification Number) 8181 Arista Place, Suite 100 Broomfield, Colorado 80021 (833) 275-2266 Registration No. 333- UNITED STATES SEC ...

Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice Chairman of Neurosurgery at Barrow Neurological Institute Dr. Uribe Becomes Aclarion's 3rd KOL With Access to a Diagnostic Center Authorized to Perform Nociscans BROOMFIELD, CO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –  Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligenc ...

Partnership aims to include Aclarion's surgical decision support technology within ATEC's AlphaInformatiX platform to better inform spine surgery Aclarion's Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine to help physicians identify the location of chronic low back pain BROOMFIELD, CO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW))), a healthcare technology company that is leveragi ...

Core Viewpoint - Aclarion, Inc. will execute a 1-for-16 reverse stock split of its common stock effective January 4, 2024, to meet Nasdaq listing standards and increase its stock price above $1.00 [1][2][4] Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders on March 24, 2023, and the Board of Directors set the ratio at 1-for-16 [2] - Post-split, the number of outstanding shares will decrease from approximately 13.4 million to about 840,000 [4] - The reverse stock split will not affect the authorized number of shares, and fractional shares will be rounded up to the nearest whole share [3][4] Group 2: Impact on Securities - The reverse stock split will also apply to outstanding warrants, stock options, and restricted stock units, with adjustments made to the number of shares and exercise prices [3] - A new CUSIP number (655187201) will be assigned to the shares, which will begin trading on a split-adjusted basis on January 4, 2024 [3] Group 3: Company Overview - Aclarion is a healthcare technology company focused on chronic low back pain, utilizing Magnetic Resonance Spectroscopy (MRS) and proprietary algorithms through its Nociscan platform [5] - Nociscan is designed to help physicians differentiate between painful and non-painful discs in the lumbar spine, providing critical insights for treatment optimization [5]

Table of Contents As filed with the Securities and Exchange Commission on December 11, 2023 Registration No. 333-______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aclarion, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8071 47-3324725 (I.R.S. Employer Identification Number) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 001-41358 ACLARION, INC. (Exact name of registrant as specified in its charter) Delaware 47-3324725 (Stat ...

Table of Contents As filed with the Securities and Exchange Commission on October 20, 2023 Registration No. 333-274914 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pre-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aclarion, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (Name, address, including zip cod ...

Table of Contents As filed with the Securities and Exchange Commission on October 10, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aclarion, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8071 47-3324725 (I.R.S. Employer Identification Number) (Addres ...